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commercially accessible quantitative analysis software, and test its
performance in a larger image dataset.
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Purpose: To assess if weight loss can improve the quality of hyaline
cartilage in patients with Knee Osteoarthritis (KOA). Cartilage quality
was assessed via delayed Gadolinium Enhanced MRI of Cartilage
(dGEMRIC) in obese patients (BMI>30) with varying degrees of KOA
using a 1.5 tesla (T) MRI scanner.
Methods: 19 patients with symptomatic KOA from a 16-week weight
loss intervention study were included from the CAROT trial
NCT00655941. Standing x-ray of target knee joints were K/L (Kellgren/
Lawrence) scored for both lateral and medial tibiofemoral compart-
ments. Patients with K/L-grade 1 and 2 in the lateral compartment were
included. K/L 3 and 4 were excluded due to the minimal quantity of
cartilage. Inversion recovery dGEMRIC with four inversion times (50,
350, 650, 1410 ms) was performed in the target knee using intra artic-
ular contrast at baseline and after 16 weeks of intervention (weight
loss). Regions of interests (ROl)s were drawn around the posterior
weight-bearing femoral knee cartilage delimited of the posterior
menisci on sagittal MRI scans. dGEMRIC T1-values were calculated at
baseline and after 16 weeks of intervention. Differences in weight loss
and dGEMRIC T1-values were compared between the two groups.
Results: 9 patients with K/L 1 and 10 patients with K/L 2 were included.
There were no group differences regarding baseline dGEMRIC T1-val-
ues: Mean 467 ms for K/L 1, and 518 ms and for K/L 2 (p ¼ 0.11), or
regarding weight loss after 16 weeks, 12.3 % and 14.3 % of BMI,
respectively (p ¼ 0.37). After 16 weeks of intervention the average
dGEMRIC T1-value increased with approximately 28 ms (CI: -29; 86) in
K/L-group 1, while the average dGEMRIC T1-value decreased 61 ms (CI:
-116;-7) for K/L-group 2. Taking baseline dGEMRIC into account, the
dGEMRIC changes between groups shows the same trend, although less
pronounced (P¼ 0.10). Reproducibility was similar to previous pub-
lications with ICCs of 0.96 for intra-reader and 0.92 for inter-reader
variability.
Conclusions: Our results indicate that improvement of cartilage quality
after weight loss may be possible in early state KOA (K/L 1), but not in
later stage KOA (K/L 2). The dGEMRIC results may suggest a point of no
return for improvement of cartilage quality. No other previous studies
have assessed this for patients with KOA. The results are similar to the
results seen in predominantly knee-healthy patients one year after
weight loss. Further studies in a larger scale are necessary to verify this
hypothesis.473
EVIDENCE OF FAULTY MATRIX REPAIR RESPONSES IN AREAS OF
DAMAGED HUMAN OSTEOARTHRITIC CARTILAGE
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Purpose: Joint degeneration in osteoarthritis is characterised by dam-
age and loss of articular cartilage. The pattern of loss is consistent with
damage occurring only where the mechanical loading is high. In pre-
vious work using RT-PCR we established that major gene changes were
similar in damaged and intact cartilage from the same OA patient and
differed from age-matched healthy non-OA cartilage. We have now
investigated using RNA sequencing (RNAseq) the gene expression
changes that occur in damaged cartilage by comparing each patients
sample with intact cartilage from the same joint. We have also recently
developed a new analytical tool, PhenomeExpress, which incorporates
published disease related ontology to identify processes most active in
the damaged tissue.
Methods: Cartilage was obtained with prior informed consent from
patients undergoing total knee replacement. Samples from 8 patients
were takenwithin 4h of surgery and tissuewas removed from an area of
damaged cartilage on the inferior medial femoral condyle (DMC)
(adjacent to the area eroded down to bone) and a paired sample was
taken from the central posterior area of the lateral condyle (PLC), which
was invariably intact. Tissue was sectioned full depth for histology and
scored using the OARSI standard score. Adjacent tissue was taken for
RNA isolation. RNAseq libraries were generated from 1 mg of total RNA
using the TruSeq® Stranded mRNA assay (Illumina, Inc.) according to
the manufacturer's protocol and sequencing was performed using the
Illumina HiSeq 2500. The raw RNAseq reads were corrected for bias
using standard bioinformatic tools, normalised to enable comparison
and then further corrected for transcript length to reﬂect gene
expression abundance.
Results: Histological grading conﬁrmed the damaged cartilage (mean ±
SD 3.8 ± 0.4) scored more than the intact cartilage (1.6 ± 0.7). The
general features of the RNAseq datasets showed that the pattern of gene
expression in the paired samples were similar. Superimposed on these
similarities were signiﬁcant changes in about 12% of the most expressed
genes comparing paired damaged with intact samples. Analysing the
whole data sets using PhenomeExpress identiﬁed 20 sub-networks of
activity changes in damaged cartilage. The most signiﬁcant of these
included inﬂammation associated gene response, cartilage develop-
ment, chondrocyte differentiation, cell proliferation and circadian
rhythm, but with no evidence of inﬂammatory cytokine expression by
chondrocytes, or of strong matrix proteinase expression. The 8 patients
all showed very high expression of COL2A1 in damaged and intact sites
and matrix protein gene expression was high in general, including
strong expression of FN1 and 8 SLRPS; LUM, FMOD, DCN, OGN, BGN,
CHAD, PRELP and ASPN. There was also high, but variable levels of
COL3A1, COL1A1 and COL1A2 expression. Changes associated with
damage showed a decline in chondrocyte phenotype, with signiﬁcantly
less SOX9, COL9A1/2/3, COL11A2 and HAPLN1 and increases in COL1A1,
COL1A2, VCAN and also in FN1, LUM, OGN, ASPN, POSTN (Periostin),
TNFRSF11B (Osteoprotegerin) and TNFAIP6 (TSG6). There was low
expression of COL10A1, which did not vary with damage and there was
no increase in ALPL (alkaline phosphatase) suggesting no progression to
hypertrophy. Although there was cell proliferation in damaged cartilage
there was only very low expression of the COL2A1 A isoform transcript,
which is associated with chondroprogenitors. Comparison of 10 OA risk
genes identiﬁed in GWAS studies revealed only low expression and no
difference between damaged and intact cartilage. As these genes are
each associated with only a very low risk of OA they would not be
predicted to be linked to cartilage damage, or indeed to necessarily be
expressed in chondrocytes.
Conclusions: The analysis reveals a pattern of gene expression with no
evidence of very active matrix degradation, but strong sustained matrix
protein and proteoglycan gene expression and particularly expression
of collagens. The changes in damaged cartilage suggest a further decline
in signals maintaining the chondrocyte phenotype. That this occurs at
sites of cartilage damage and eventual loss shows that this response is
unable to halt or reverse the damage and it may be the inappropriate
matrix gene expression that causes a failed repair. Further detailed
